Multicomponent self-assembly of Mn
2
(CO)
10
, a bis-chelating aminoquinonato (ON∩ON)
bridge (L), and an
ester/amide-functionalized flexible neutral ditopic linker (L′)
has resulted into the formation of M
2
LL′-type manganese(I)-based
dinuclear metallastirrups of general formula [{(CO)
3
Mn(μ-η
4
-L)Mn(CO)
3
}(μ-L′)] (
1
–
10
). Compounds
1
–
10
were accomplished via orthogonal bonding of the aminoquinone ligand
(2,5-bis(
n
-butylamino)-1,4-benzoquinone/2,5-bis(phenethylamino)-1,4-benzoquinone)
and ditopic pyridyl ligand to manganese carbonyl. The resultant metallastirrups
were characterized using elemental analyses and IR, UV–vis,
1
H NMR, and electrospray ionization-mass spectroscopic techniques.
The molecular structure of
6
was confirmed by single-crystal
X-ray diffraction methods. Furthermore, molecular recognition capabilities
of
1
,
5
,
7
, and
9
were evaluated with aromatic compounds containing hydroxy/amine
functionalities. Anticancer activities of compounds
1
−
3
,
5
−
7
,
9
, and
10
were investigated against three cancer
cell lines, that is, lung (A549), colon (HCT-15), and cervical (HeLa)
as well as on normal cells (HEK 293). Compound
9
showed
a broad-spectrum inhibition toward these cancer cells upon exposure
to visible light. The myoglobin assay was performed using UV–vis
absorption spectroscopy to investigate the visible-light-triggered
CO release from
5
and
9
that could be related
to their ability to effectively inhibit cancer cells. In addition,
morphological studies confirmed the induction of autophagy due to
the treatment of cancer cells using compound
9
.